Niesha Griffith

563 total citations
21 papers, 402 citations indexed

About

Niesha Griffith is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, Niesha Griffith has authored 21 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Geriatrics and Gerontology, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in Physiology. Recurrent topics in Niesha Griffith's work include Pharmaceutical Practices and Patient Outcomes (9 papers), Pharmaceutical studies and practices (6 papers) and Patient Safety and Medication Errors (4 papers). Niesha Griffith is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (9 papers), Pharmaceutical studies and practices (6 papers) and Patient Safety and Medication Errors (4 papers). Niesha Griffith collaborates with scholars based in United States, Australia and Switzerland. Niesha Griffith's co-authors include James M. Hoffman, Ali McBride, Susan Goodin, Raymond J. Muller, Lisa M. Holle, Rowena Schwartz, Judy L. Chase, Robert DeChristoforo, Barry R. Goldspiel and James G. Stevenson and has published in prestigious journals such as Supportive Care in Cancer, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Biology of Blood and Marrow Transplantation.

In The Last Decade

Niesha Griffith

20 papers receiving 386 citations

Peers

Niesha Griffith

PPCH

Scott W. Savage United States

John Valgus United States

Rowell Daniels United States

Rosa Romero‐Jiménez Spain

James A. Jorgenson United States

Jill Bates United States

Dorothee C. Dartsch Germany

Hans-Martin Späth France

Jane M. Pruemer United States

Eve M. Segal United States

Scott W. Savage United States

Niesha Griffith

89 ×0.6

PPCH

133 ×1.1

39 ×0.3

37 ×0.5

28 ×0.5

Citations per year, relative to Niesha Griffith Niesha Griffith (= 1×) peers Scott W. Savage

Countries citing papers authored by Niesha Griffith

Since Specialization

Citations

This map shows the geographic impact of Niesha Griffith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niesha Griffith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niesha Griffith more than expected).

Fields of papers citing papers by Niesha Griffith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niesha Griffith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niesha Griffith. The network helps show where Niesha Griffith may publish in the future.

Co-authorship network of co-authors of Niesha Griffith

This figure shows the co-authorship network connecting the top 25 collaborators of Niesha Griffith. A scholar is included among the top collaborators of Niesha Griffith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niesha Griffith. Niesha Griffith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gilmore, James, et al.. (2018). Recent advances in antiemetics: new formulations of 5HT<sub>3</sub>-receptor antagonists. Cancer Management and Research. Volume 10. 1827–1857. 20 indexed citations

Poi, Ming, et al.. (2017). National survey of comprehensive pharmacy services provided in cancer clinical trials. American Journal of Health-System Pharmacy. 74(11_Supplement_2). S35–S41. 6 indexed citations

Li, Quan, et al.. (2016). Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions. American Journal of Health-System Pharmacy. 73(17). 1331–1337. 11 indexed citations

Goldspiel, Barry R., James M. Hoffman, Niesha Griffith, et al.. (2015). ASHP Guidelines on Preventing Medication Errors with Chemotherapy and Biotherapy. American Journal of Health-System Pharmacy. 72(8). e6–e35. 63 indexed citations

Griffith, Niesha, et al.. (2014). Physicians as Executives: Opportunities and Strategies for Health-System Pharmacy Leaders. Hospital Pharmacy. 49(10). 985–991. 3 indexed citations

Griffith, Niesha, Ali McBride, James G. Stevenson, & Larry Green. (2014). Formulary Selection Criteria for Biosimilars: Considerations for US Health-System Pharmacists. Hospital Pharmacy. 49(9). 813–825. 26 indexed citations

Berger, Michael, Marlo Blazer, Brooke Crawford, et al.. (2013). Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy. Supportive Care in Cancer. 21(10). 2845–2851. 19 indexed citations

Poi, Ming, Ali McBride, Julianna Roddy, et al.. (2013). A Prospective, Double-Blinded, Observational Clinical Cohort Study of the Association Between Tacrolimus Exposure and CYP3A4, CYP3A5 Genotypes in Adult Hematopoietic Stem Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 19(2). S380–S380. 1 indexed citations

Frame, James N., Joseph O. Jacobson, Wendy Vogel, et al.. (2013). Assessment of Risk Evaluation and Mitigation Strategies in Oncology: Summary of the Oncology Risk Evaluation and Mitigation Strategies Workshop. Journal of Oncology Practice. 9(2). e24–e39. 9 indexed citations

10.

McBride, Ali, et al.. (2013). National survey on the effect of oncology drug shortages on cancer care. American Journal of Health-System Pharmacy. 70(7). 609–617. 83 indexed citations

11.

Blazer, Marlo, Gary Phillips, Joshua Reardon, et al.. (2012). Antiemetic Control with Palonosetron in Patients with Gastrointestinal Cancer Receiving a Fluoropyrimidine-Based Regimen in Addition to Either Irinotecan or Oxaliplatin: A Retrospective Study. Oncology. 83(3). 135–140. 2 indexed citations

12.

Chau, Katrina, et al.. (2012). Levetiracetam-induced severe acute granulomatous interstitial nephritis. Clinical Kidney Journal. 5(3). 234–236. 15 indexed citations

13.

Griffith, Niesha, et al.. (2011). Safe handling of oral chemotherapeutic agents: A European perspective. 5(2). 4–10. 3 indexed citations

14.

Goodin, Susan, et al.. (2011). Safe Handling of Oral Chemotherapeutic Agents in Clinical Practice: Recommendations From an International Pharmacy Panel. Journal of Oncology Practice. 7(1). 7–12. 79 indexed citations

15.

Griffith, Niesha, et al.. (2008). The Impact of a Long-Acting Erythropoiesis Stimulating Protein on Patient Throughput in a Hospital-Based Ambulatory Oncology Clinic. Hospital Pharmacy. 43(5). 388–395. 3 indexed citations

16.

Arbuckle, Rebecca, Niesha Griffith, Philip E. Johnson, et al.. (2008). Continued Challenges with the Use of Erythropoiesis‐Stimulating Agents in Patients with Cancer: Perspectives and Issues on Policy‐Guided Health Care. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(5P2). 9 indexed citations

17.

Griffith, Niesha, et al.. (2007). Medication Tracers: A Systems Approach to Medication Safety. Hospital Pharmacy. 42(10). 916–920. 1 indexed citations

18.

Szeinbach, Sheryl L., et al.. (2002). Perceptions of quality and value in state and local pharmacy professional organizations. American Journal of Health-System Pharmacy. 59(11). 1082–1089. 2 indexed citations

19.

Pedersen, Craig A., et al.. (2001). Policies on documentation and disciplinary action in hospital pharmacies after a medication error. American Journal of Health-System Pharmacy. 58(12). 1120–1125. 2 indexed citations

20.

Griffith, Niesha, et al.. (1998). Survey of inpatient counseling by hospital pharmacists. American Journal of Health-System Pharmacy. 55(11). 1127–1133. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact